6.
Carter S, Seiff S
. Macular changes in pseudotumor cerebri before and after optic nerve sheath fenestration. Ophthalmology. 1995; 102(6):937-41.
DOI: 10.1016/s0161-6420(95)30931-1.
View
7.
Chen J, Thurtell M, Longmuir R, Garvin M, Wang J, Wall M
. Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension. Invest Ophthalmol Vis Sci. 2015; 56(6):3850-9.
PMC: 4697859.
DOI: 10.1167/iovs.15-16450.
View
8.
Albrecht P, Blasberg C, Ringelstein M, Muller A, Finis D, Guthoff R
. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol. 2017; 264(7):1370-1380.
DOI: 10.1007/s00415-017-8532-x.
View
9.
Kwapong W, Cao L, Pan R, Wang H, Ye C, Tao W
. Retinal microvascular and structural changes in intracranial hypertension patients correlate with intracranial pressure. CNS Neurosci Ther. 2023; 29(12):4093-4101.
PMC: 10651994.
DOI: 10.1111/cns.14298.
View
10.
Dreesbach M, Joachimsen L, Kuchlin S, Reich M, Gross N, Brandt A
. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension. Transl Vis Sci Technol. 2020; 9(3):24.
PMC: 7354856.
DOI: 10.1167/tvst.9.3.24.
View
11.
Vujosevic S, Parra M, Hartnett M, OToole L, Nuzzi A, Limoli C
. Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children. Eye (Lond). 2022; 37(2):203-219.
PMC: 9012155.
DOI: 10.1038/s41433-022-02056-9.
View
12.
Scott C, Kardon R, Lee A, Frisen L, Wall M
. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010; 128(6):705-11.
DOI: 10.1001/archophthalmol.2010.94.
View
13.
Tranos P, Wickremasinghe S, Stangos N, Topouzis F, Tsinopoulos I, Pavesio C
. Macular edema. Surv Ophthalmol. 2004; 49(5):470-90.
DOI: 10.1016/j.survophthal.2004.06.002.
View
14.
Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J
. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014; 55(12):8173-9.
PMC: 4266073.
DOI: 10.1167/iovs.14-14961.
View
15.
Bingol Kiziltunc P, Atilla H
. A novel biomarker for increased intracranial pressure in idiopathic intracranial hypertension. Jpn J Ophthalmol. 2021; 65(3):416-422.
DOI: 10.1007/s10384-020-00807-3.
View
16.
Nogueira P, Caiado G, Gracitelli C, Martins F, Barros F, Matas S
. Association between Optical Coherence Tomography Measurements and Clinical Parameters in Idiopathic Intracranial Hypertension. J Ophthalmol. 2021; 2021:1401609.
PMC: 7857887.
DOI: 10.1155/2021/1401609.
View
17.
Huang-Link Y, Eleftheriou A, Yang G, Johansson J, Apostolou A, Link H
. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema. Eur J Neurol. 2018; 26(5):808-e57.
DOI: 10.1111/ene.13893.
View
18.
Vijay V, Mollan S, Mitchell J, Bilton E, Alimajstorovic Z, Markey K
. Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension. JAMA Ophthalmol. 2020; 138(12):1264-1271.
PMC: 7582233.
DOI: 10.1001/jamaophthalmol.2020.4242.
View
19.
Xie J, Donaldson L, Margolin E
. Papilledema: A review of etiology, pathophysiology, diagnosis, and management. Surv Ophthalmol. 2021; 67(4):1135-1159.
DOI: 10.1016/j.survophthal.2021.11.007.
View
20.
Nichani P, Micieli J
. Retinal Manifestations of Idiopathic Intracranial Hypertension. Ophthalmol Retina. 2020; 5(5):429-437.
DOI: 10.1016/j.oret.2020.08.016.
View